NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Whole-saliva proteolysis and its impact on salivary diagnostics.

Author(s): Thomadaki K, Helmerhorst EJ, Tian N, Sun X, Siqueira WL, Walt DR, Oppenheim FG

Publication: J Dent Res, 2011, Vol. 90, Page 1325-30

PubMed ID: 21917601 PubMed Review Paper? No

Suggested by: Eva J. Helmerhorst, Boston University


Purpose of Paper

The purpose of this paper was to determine the effects of 19 different protease inhibitors, pH, storage duration and temperature and boiling on the saliva proteome and the stability of exogenous histatin 5.

Conclusion of Paper

Only 5 of the tested protease inhibitors prevented hydrolysis, but even when these 5 were combined with EDTA, saliva proteome degradation was only partially attenuated. Reducing the pH of saliva specimens to 3.0 or increasing the pH to 10.0 stabilized the native proteins, but only reducing the pH to 3.0 stabilized exogenous histatin 5. As expected, histatin 5 degradation increased with increasing saliva storage temperature. Boiling the specimens (10 min at 100°C) increased the 1/2 life of histatin 5 at 37°C from 15 min to 9 h.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of 19 different protease inhibitors, pH, storage duration and temperature, and boiling on the saliva proteome and the stability of exogenous histatin 5. Saliva was obtained from 5 individuals after 10 min mastication of paraffin wax. All specimens were pooled, placed on ice and aliquoted. Some aliquots were centrifuged for 20 min at 14,000 g at 4°C. Hydrolytic activity was assayed by monitoring the fluorescence after addition of the substrates benzyloxycarbonyl-Phe-His-Glu-Lys-7-amino-4-methylcoumarin (Z-FHEK-AMC) and benzyloxycarbonyl-Arg-Gly-Tyr-Arg-7-amino-4-methylcoumarin (Z-RGYR-AMC). Saliva pH was adjusted by the addition of hydrochloric acid or sodium hydroxide.

    Summary of Findings:

    Of the 19 protease inhibitors tested, only 4-benzenesulfonyl fluoride hydrochloride (AEBSF), aprotinin, pancreatic trypsin inhibitor, leupeptin, and antipain showed >85% inhibition of the hydrolysis of exogenous Z-FHEK-AMC and Z-RGYR-AMC. A cocktail of the 5 effective protease inhibitors and EDTA attenuated changes in the proteome peak patterns and delayed degradation of exogenous histatin 5, statherin, and proline-rich protein 1 (PRP1) during 8 h of storage at 37°C in uncentrifuged saliva and even more so in centrifuged saliva. While decreasing the pH to 4.0 had little effect on endogenous protein stability at 37°C, it stabilized histatin-5 for 5 h (as opposed to <1 h), and further decreasing the pH to 3.0 stabilized the endogenous proteome and exogenous histatin-5 for 24 h. Increasing the pH to 10.0 also stabilized the endogenous proteome but only had a small effect on histatin-5 stability. The 1/2 life of histatin 5 decreased with increasing storage temperature (4 h 20 min, 3 h 10 min, 35 min and 22 min at 0°C, 4°C, 22°C, and 37°C, respectively). Boiling the specimens (10 min in a 100°C water bath) increased the 1/2 life of histatin 5 at 37°C from 15 min to 9 h.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Peptide 1D/2D gels
    Peptide HPLC
    Protein Fluorometry
    Protein HPLC
    Protein 1D/2D gels
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components pH 3
    4
    7.2
    10
    Biospecimen Aliquots and Components Centrifugation Not centrifuged
    Centrifuged
    Biospecimen Aliquots and Components Biospecimen components Histatin 5 added
    Statherin added
    PRP1 added
    Storage Storage temperature 0°C
    4°C
    22°C
    37°C
    Storage Storage duration 0 min
    5 min
    15 min
    30 min
    1 h
    1.5 h
    3 h
    5 h
    7 h
    8 h
    24 h
    Analyte Extraction and Purification Protease inhibitor Alpha-1 antitrypsin
    Soybean trypsin inhibitor
    Chymostatin
    6-Aminohexanoic acid
    E-64
    N-ethylmalemide
    Phosphoramidon
    Bestatin
    Pepstatin
    Aprotinin
    Pancreatic trypsin inhibitor
    Leupeptin
    Antipain
    EDTA
    2-PDS
    4-(2-aminoethyl)-benzenesulfonylfluoride (AEBSF)
    PMSF
    Benzenecarboximidamide (benzamidine)
    TLCK
    Storage Storage conditions Boiled
    Not boiled

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...